SCHEMBL7651507

SCHEMBL7651507

FC(F)(F)COc1ccc(OC(F)(F)F)cc1Br

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
MAPT P10636 4/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
CYP2C9 P11712 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 8/20 0.41
THRB P10828 2/20 0.41
USP2 O75604 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
G6PD P11413 1/20 0.41
ALOX15 P16050 1/20 0.41
CASP1 P29466 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP1A2 P05177 1/20 0.40
POLB P06746 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8156344 0.88 KDM4E (0.56) KDM4EMAPTMEN1KMT2ACYP2C9
SCHEMBL8148399 0.83 S1PR1 (0.46) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL5158453 0.82 ALDH1A1 (0.46) MEN1KMT2ACYP2D6CYP2C19ALDH1A1
SCHEMBL8163202 0.82 FFAR1 (0.39) MAPTCYP2C9CYP2D6CYP2C19ALDH1A1
SCHEMBL19616709 0.81 MAPT (0.43) KDM4EMAPTALDH1A1THRBL3MBTL1
SCHEMBL29493403 0.81 MAPT (0.43) KDM4EMAPTALDH1A1THRBL3MBTL1
SCHEMBL8156359 0.81 MCHR1 (0.47) CYP2C9ALDH1A1THRBPOLBGAA
SCHEMBL27493434 0.80 ALDH1A1 (0.48) MAPTMEN1KMT2AALDH1A1THRB
SCHEMBL8156773 0.80 MEN1 (0.41) KDM4EMAPTMEN1KMT2ACYP2D6
SCHEMBL25998819 0.80 ALDH1A1 (0.45) ALDH1A1THRBPOLBGAAGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372754-B1 DRUGS FOR TREATMENT OR PREVENTION OF DEPRESSION, ANXIETY, PAIN, INFLAMMATION, MIGRAINE, EMESIS OR POSTHERPIC NEURALGIA. MERCK SHARP & DOHME LTD. 2002-04-16 US disclosed
EP-1161419-A1 SPIROCYCLIC KETONES AND THEIR USE AS TACHYKININ ANTAGONISTS MERCK SHARP & DOHME LTD. (GB) 2001-12-12 EP disclosed
WO-2000047562-A1 SPIROCYCLIC KETONES AND THEIR USE AS TACHYKININ ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 2000-08-17 WO disclosed
US-6071927-A Spiro-piperidine derivatives and their use as therapeutic agents MERCK SHARP & DOHME LTD. (GB) 2000-06-06 US disclosed